Gene expression of peripheral blood lymphocytes may discriminate patients with schizophrenia from controls

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 1018-1021

  Maschietto, Mariana ^a,b   Silva, Aderbal R ^a,b   Puga, Renato D ^b   Lima, Leandro ^b   Pereira, Carlos B ^a   Nakano, Eduardo Y ^a   Mello, Barbara ^b   Gama, Clarissa S ^c   Belmonte de Abreu, Paulo ^c   Carraro, Dirce M ^b   Palha, Joana A ^d   Brentani, Helena ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF MINHO   (Portugal)

Author keywords

Drugs; Peripheral Molecular Marker; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 16P; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; HERPUD1 GENE; HOXA13 GENE; HUMAN; HUMAN CELL; MALAT1 GENE; MOLECULAR DYNAMICS; OUTCOME ASSESSMENT; PERIPHERAL LYMPHOCYTE; PIK3R3 GENE; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SULT1A1 GENE;

ADULT; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LYMPHOCYTES; MALE; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY;

EID: 84872370317     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.04.030     Document Type: Article

References (35)

1. Bonci A., Hopf F.W. The dopamine D2 receptor: new surprises from an old friend. Neuron 2005, 47:335-338.
2. Bowden N.A., Weidenhofer J., Scott R.J., Schall U., Todd J., Michie P.T., Tooney P.A. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr Research 2006, 82:175-183.
3. Cline M.S., Smoot M., Cerami E., Kuchinsky A., Landys N., Workman C., Christmas R., Avila-Campilo I., Creech M., Gross B., Hanspers K., Isserlin R., Kelley R., Killcoyne S., Lotia S., Maere S., Morris J., Ono K., Pavlovic V., Pico A.R., Vailaya A., Wang P.L., Adler A., Conklin B.R., Hood L., Kuiper M., Sander C., Schmulevich I., Schwikowski B., Warner G.J., Ideker T., Bader G.D. Integration of biological networks and gene expression data using Cytoscape. Nature Protocols 2007, 2:2366-2382.
4. Colantuoni C., Lipska B.K., Ye T., Hyde T.M., Tao R., Leek J.T., Colantuoni E.A., Elkahloun A.G., Herman M.M., Weinberger D.R., Kleinman J.E. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011, 478:519-523.
5. De Leona A., Carriere K. A generalized Mahalanobis distance for mixed data. Journal of Multivariate Analysis 2005, 92. 11 (Elsevier).
6. Domenici E., Willé D.R., Tozzi F., Prokopenko I., Miller S., McKeown A., Brittain C., Rujescu D., Giegling I., Turck C.W., Holsboer F., Bullmore E.T., Middleton L., Merlo-Pich E., Alexander R.C., Muglia P. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One 2010, 5:e9166.
7. Fan Y., Abrahamsen G., McGrath J.J., Mackay-Sim A. Altered cell cycle dynamics in schizophrenia. Biological Psychiatry 2012, 71:129-135.
8. Fukuoka Y., Inaoka H., Kohane I.S. Inter-species differences of co-expression of neighboring genes in eukaryotic genomes. BMC Genomics 2004, 5(4).
9. Glatt S.J., Everall I.P., Kremen W.S., Corbeil J., Sásik R., Khanlou N., Han M., Liew C.C., Tsuang M.T. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proceedings of the Natlonal Academy of Science of the United States of America 2005, 102:15533-15538.
10. Ilani T., Ben-Shachar D., Strous R.D., Mazor M., Sheinkman A., Kotler M., Fuchs S. A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proceedings of the Natlonal Academy of Science of the United States of America 2001, 98:625-628.
11. Kuzman M.R., Medved V., Terzic J., Krainc D. Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia. Journal of Psychiatric Research 2009, 43:1073-1077.
12. Martins-de-Souza D., Gattaz W.F., Schmitt A., Maccarrone G., Hunyadi-Gulyás E., Eberlin M.N., Souza G.H., Marangoni S., Novello J.C., Turck C.W., Dias-Neto E. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. Journal of Psychiatric Research 2009, 43:978-986.
13. Martins-de-Souza D., Maccarrone G., Wobrock T., Zerr I., Gormanns P., Reckow S., Falkai P., Schmitt A., Turck C.W. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. Journal of Psychiatric Research 2010, 44:1176-1189.
14. Maschietto M., Trape A.P., Piccoli F.S., Ricca T.I., Dias A.A.M., Coudry R.A., Galante P.A., Torres C., Fahhan L., Lourenco S., Grundy P.E., de Camargo B., de Souza S., Neves E.J., Soares F.A., Brentani H., Carraro D.M. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset. Cell Death & Disease 2011, 2.
15. Mello B.P., Abrantes E.F., Torres C.H., Machado-Lima A., RaS Fonseca, Carraro D.M., Brentani R.R., Reis L.F., Brentani H. No-match ORESTES explored as tumor markers. Nucleic Acids Research 2009, 37:2607-2617.
16. Nakamura A., Nakajima M., Yamanaka H., Fujiwara R., Yokoi T. Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metabolism Disposition 2008, 36:1461-1464.
17. Ng M.Y., Levinson D.F., Faraone S.V., Suarez B.K., DeLisi L.E., Arinami T., Riley B., Paunio T., Pulver A.E., Irmansyah Holmans PA, Escamilla M., Wildenauer D.B., Williams N.M., Laurent C., Mowry B.J., Brzustowicz L.M., Maziade M., Sklar P., Garver D.L., Abecasis G.R., Lerer B., Fallin M.D., Gurling H.M., Gejman P.V., Lindholm E., Moises H.W., Byerley W., Wijsman E.M., Forabosco P., Tsuang M.T., Hwu H.G., Okazaki Y., Kendler K.S., Wormley B., Fanous A., Walsh D., O'Neill F.A., Peltonen L., Nestadt G., Lasseter V.K., Liang K.Y., Papadimitriou G.M., Dikeos D.G., Schwab S.G., Owen M.J., O'Donovan M.C., Norton N., Hare E., Raventos H., Nicolini H., Albus M., Maier W., Nimgaonkar V.L., Terenius L., Mallet J., Jay M., Godard S., Nertney D., Alexander M., Crowe R.R., Silverman J.M., Bassett A.S., Roy M.A., Mérette C., Pato C.N., Pato M.T., Roos J.L., Kohn Y., Amann-Zalcenstein D., Kalsi G., McQuillin A., Curtis D., Brynjolfson J., Sigmundsson T., Petursson H., Sanders A.R., Duan J., Jazin E., Myles-Worsley M., Karayiorgou M., Lewis C.M. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Molecular Psychiatry 2009, 14:774-785.
18. Palha J.A., Goodman A.B. Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Res Rev 2006, 51:61-71.
19. Paulsen B.D., Maciel R.D., Galina A., da Silveira M.S., Souza C.D., Drummond H., Pozzato E.N., Junior H.S., Chicaybam L., Massuda R., Setti-Perdigão P., Bonamino M., Belmonte-de-Abreu P.S., Castro N.G., Brentani H., Rehen S.K. Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplantation 2011.
20. Prifti E., Zucker J.D., Clement K., Henegar C. FunNet: an integrative tool for exploring transcriptional interactions. Bioinformatics 2008, 24:2636-2638.
21. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P., Consortium I.S. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
22. Ruano D., Aulchenko Y.S., Macedo A., Soares M.J., Valente J., Azevedo M.H., Hutz M.H., Gama C.S., Lobato M.I., Belmonte-de-Abreu P., Goodman A.B., Pato C., Heutink P., Palha J.A. Association of the gene encoding neurogranin with schizophrenia in males. Journal of Psychiatric Research 2008, 42:125-133.
23. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
24. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757.
25. Slodzinski H., Moran L.B., Michael G.J., Wang B., Novoselov S., Cheetham M.E., Pearce R.K., Graeber M.B. Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies. Clinical Neuropathology 2009, 28:333-343.
26. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietiläinen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Børglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Böttcher Y., Olesen J., Breuer R., Möller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Réthelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U, Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jönsson E.G., Terenius L., Agartz I., Petursson H., Nöthen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A., (GROUP) GRaOiP Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
27. Sullivan P.F., Fan C., Perou C.M. Evaluating the comparability of gene expression in blood and brain. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006, 141B:261-268.
28. Sun J., Jia P., Fanous A.H., van den Oord E., Chen X., Riley B.P., Amdur R.L., Kendler K.S., Zhao Z. Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS One 2010, 5:e11351.
29. Tsuang M.T., Nossova N., Yager T., Tsuang M.M., Guo S.C., Shyu K.G., Glatt S.J., Liew C.C. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2005, 133B:1-5.
30. Tsuang M.T., Stone W.S., Faraone S.V. Genes, environment and schizophrenia. British Journal of Psychiatry Suppl. 2001, 40:s18-s24.
31. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the Natlonal Academy of Science of the United States of America 2001, 98:5116-5121.
32. Vidal M., Cusick M.E., Barabási A.L. Interactome networks and human disease. Cell 2011, 144:986-998.
33. Woelk C.H., Singhania A., Pérez-Santiago J., Glatt S.J., Tsuang M.T. The utility of gene expression in blood cells for diagnosing neuropsychiatric disorders. International Review of Neurobiology 2011, 101:41-63.
34. Zhan L., Kerr J.R., Lafuente M.J., Maclean A., Chibalina M.V., Liu B., Burke B., Bevan S., Nasir J. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathology and Applied Neurobiology 2011, 37:206-219.
35. Zhang B., Kirov S., Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005, 33:W741-W748.